In this practical webinar sponsored by AstraZeneca and Daiichi Sankyo, we'll be taking a closer look at how to optimise the patient experience on Enhertu.
Join us for an expert-led webinar, sponsored by AstraZeneca and Daiichi Sankyo, on navigating the metastatic breast cancer treatment landscape, with a focus on optimising patient care with Enhertu (trastuzumab deruxtecan) for HER2-positive and HER2-low metastatic breast cancer. This session will explore the latest evidence, practical considerations, and real-world applications of Enhertu in clinical practice, equipping you with the knowledge and expertise to contribute to improved patient outcomes.
This webinar will provide practical insights into:
Patient selection and eligibility for Enhertu
Managing toxicities and treatment-related considerations
Optimising supportive care for patients on Enhertu
Real-world case discussion
CNSA is grateful to Daiichi Sankyo and Astra Zeneca for sponsoring this educational event.
Consultant Medical Oncologist in the Breast service , Lakeside Specialist Breast Clinic and Nepean Cancer Care Centre
Consultant Medical Oncologist in the Breast service , Lakeside Specialist Breast Clinic and Nepean Cancer Care Centre
Dr Dhanusha Sabanathan is a Consultant Medical Oncologist in the Breast service at the Lakeside Specialist Breast Clinic and Nepean Cancer Care Centre. She also holds an academic appointment as a Senior Lecturer at the University of Sydney and Macquarie University. Her clinical practice and research are devoted to the treatment of breast cancer with a personalised holistic approach using the latest evidence based medicine.
After graduating in Medicine from the University of New South Wales Dr Sabanathan completed her specialty training in Medical Oncology at the Crown Princess Mary Cancer Care Centre. Dr Sabanathan completed her Post Graduate Fellowship in Clinical Trials at Westmead Hospital and Macquarie University. During this training she has specialised in early phase trials and has also completed a Masters of Research. She has recently submitted her PhD thesis looking at a Phase I trial in advanced solid tumors. She has also completed a Master of Medicine in Clinical Epidemiology at the University of Sydney. She is widely published and has presented her work at national and international meetings.
Dr Sabanathan is a member of the Royal Australian College of Physicians and an active member of the Breast Cancer Trials Group, Australia. Dhanusha is committed to ensuring high quality research findings are translated into clinical practice and her team pride themselves on providing optimal personalised care.
Nurse Practitioner in Breast Oncology, Macquarie University Hospital
Jenny is a Nurse Practitioner in Breast Oncology at MUH,, one of only four Australia. She also works for the McGrath Foundation as the Chief Clinical Lead for the Metastatic McGrath Breast Cancer nurses. Jenny has 20 years nursing experience and holds an honorary position as Senior Clinical Lecturer at Macquarie University. She a member on the board of directors of the Australasian Society for Breast Diseases, a member of the strategic advisory group for BCNA and is heavily involved in the oncology aspect of the Macquarie MD program. Jenny is a principal investigator and sub-investigator on several breast cancer clinical trials at Macquarie University. Her clinical interests include careMembers, welcome to our new website! To access your account for the first time, you’ll need to enter a new password.
Simply click the ‘Forgotten Password’ link on the login page to create a new one.
If you need any assistance, we’re here to help - just reach out!